Profile of tirzepatide in the management of type 2 diabetes mellitus: design, development, and place in therapy
Open Access
- 26 February 2023
- journal article
- research article
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 24 (4) , 407-418
Abstract
Type 2 diabetes mellitus (T2DM) is one of the leading causes of morbidity and mortality. Peptide-based multi-targeting agonists represent a new paradigm in metabolic pharmacology as they manifest m...Keywords
This publication has 53 references indexed in Scilit:
- A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart diseaseScience Translational Medicine, 2016
- A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With HypertriglyceridemiaThe American Journal of Cardiology, 2016
- Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a reviewClinical & Experimental Ophthalmology, 2016
- Pancreatic Safety of Incretin-Based Drugs — FDA and EMA AssessmentNew England Journal of Medicine, 2014
- Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and HumansScience Translational Medicine, 2013
- Why Young Adults Hold the Key to Assessing the Obesity Epidemic in ChildrenArchives of Pediatrics & Adolescent Medicine, 2008
- Resistin Is a Key Mediator of Glucose-dependent Insulinotropic Polypeptide (GIP) Stimulation of Lipoprotein Lipase (LPL) Activity in AdipocytesJournal of Biological Chemistry, 2007
- Immunohistochemical distribution of glucose‐dependent insulinotropic polypeptide in the adult rat brainJournal of Neuroscience Research, 2007
- Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapyMetabolism, 2004
- Accurate Assessment of β-Cell FunctionDiabetes, 2002